FDA Acknowledged That Vaccine Technology Outpacing Ability to Predict Adverse Events
“One of the important things is that the technology used to make these vaccines actually exceeds the science and technology to understand how these vaccines work and to predict how they will work,” stated Dr. Peter Patriarca, MD, Director of the Viral Products Division of the FDA Center for Biological Evaluation and Research (CBER). “So this has the potential for ending up in a situation which I call a “black box” vaccine” referring to a situation of unforeseen and unpredictable vaccine outcomes.”
DOWNLOAD HOTLINKS TO THE STUDIES BELOW
Ahmed SS, Steinman L. 2017. Narcolepsy and influenza vaccination-induced autoimmunity.Ann Transl Med. 5(1):25. doi: 10.21037/atm.2016.12.63.
Crépeaux G, Eidi H, David MO, Baba-Amer Y, Tzavara E, Giros B, Authier FJ, Exley C, Shaw CA, Cadusseau J, Gherardi RK. 2017. Non-linear dose-response of aluminium hydroxide adjuvant particles: Selective low dose neurotoxicity. Toxicology. 375:48-57. doi: 10.1016/j.tox.2016.11.018.
Lyons-Weiler, J and R. Ricketson. 2018. Reconsideration of the Immunotherapeutic Pediatric Safe Dose Levels of Aluminum. Journal and Trace Elements in Medicine and Biology 48:67-73.
Lyons-Weiler, J. 2018b. Autism is an Acquired Cellular Detoxification Deficiency Syndrome with Heterogeneous Genetic Predisposition. Autism Open Access 8(1):1-17. doi: 10.4172/2165-7890.1000224
Masson JD, Crépeaux G, Authier FJ, Exley C, Gherardi RK. 2018. Critical analysis of reference studies on the toxicokinetics of aluminum-based adjuvants. J Inorg Biochem. 181:87-95. doi: 10.1016/j.jinorgbio.2017.12.015.
Mold M, Umar D, King A, Exley C. 2018. Aluminium in brain tissue in autism. J Trace Elem Med Biol. 46:76-82. doi: 10.1016/j.jtemb.2017.11.012.
Morris G, Puri BK, Frye RE. 2017. The putative role of environmental aluminium in the development of chronic neuropathology in adults and children. How strong is the evidence and what could be the mechanisms involved? Metab Brain Dis.;32(5):1335-1355. doi: 10.1007/s11011-017-0077-2.
Sokol DK, Chen D, Farlow MR, Dunn DW, Maloney B, Zimmer JA, Lahiri DK. 2006. High levels of Alzheimer beta-amyloid precursor protein (APP) in children with severely autistic behavior and aggression. J Child Neurol. 21(6):444-9.
Stamogiannos A, Papakyriakou A, Mauvais FX, van Endert P, Stratikos E 2016. Screening Identifies Thimerosal as a Selective Inhibitor of Endoplasmic Reticulum Aminopeptidase 1. ACS Med Chem Lett. 7(7):681-5. doi: 10.1021/acsmedchemlett.6b00084.
Folate and vitamin B12 may play a critical role in lowering the HPV 16 methylation-associated risk of developing higher grades of CIN.
There are more than 100 types of HPV, of which at least 13 are cancer-causing (also known as high risk type). HPV 16 is considered a cancer causing strain.
Comment: Toni Bark, MD MHEM LEED AP, Evanston, Illinois
“OBGYN taught me 30 yrs ago to give folate, b vitamin complex along with vitamins, A C and E and zinc, to patients with abnormal paps before committing them to Leap procedures. I never had to send a patient to another procedure. Granted I wasn’t using methylated folate and didn’t know about MTHFR variances, at the time, butiI was still successful”.
VLA Comment: If you are in Illinois, we highly recommend Dr. Bark as your physician.
HPV infection Natural Cure Study
Could a Japanese mushroom extract be the cure for HPV, the virus that causes cervical cancer?
It’s a potential breakthrough in treating the currently untreatable human papilloma virus (HPV) — one that comes directly from nature.
At a recent Society for Integrative Oncology conference, Judith A. Smith, a pharmacist and an associate professor at the University of Texas Health Science Center at Houston Medical School, presented the results of a small study that found the supplement active hexose correlated compound (AHCC) can eliminate the HPV virus.
VLA Comment: There are more than 100 types of HPV, of which at least 13 are cancer-causing (also known as high risk type). The japanese mushroom has proved to cure many of the strains. And I have personal proof of that. It is a great breakthrough.
JOURNAL OF TRACE ELEMENTS IN MEDICINE AND BIOLOGY
On Day 1 of life, infants receive 17 times more aluminum than would be allowed if doses were adjusted per body weight.
FDA regulations require safety testing of constituent ingredients in drugs (21 CFR 610.15). With the exception of extraneous proteins, no component safety testing is required for vaccines or vaccine schedules. The dosing of aluminum in vaccines is based on the production of antibody titers, not safety science. Here we estimate a Pediatric Dose Limit that considers body weight. We identify several serious historical missteps in past analyses of provisional safe levels of aluminum in vaccines, and provide updates relevant to infant aluminum exposure in the pediatric schedule considering pediatric body weight
The small quantity of aluminum retained in the body
accumulates over time. Most of the aluminum that accumulates
(50 to 60 percent) settles in the bones, some in the lungs (about 25
percent) and some in the brain (about 1 percent). The remaining
quantities are distributed in serum, skin, gastrointestinal tract, lymph
nodes and glands. In fact, low quantities of aluminum can be found
in most organs.
VLA comment: Apparently it is okay with the CDC and Paul Offit at the Philadelphia Children’s Hospital that…and I quote and excerpt…the process which a small infant has to deal with excreting this poison or the consequences of retain the metal in the bones or the brains is inconsequental:
Pharmacokinetics and Differential Regulation of Cytochrome P450 Enzymes in Type 1 Allergic Mice
“We investigated hepatic P450 metabolism and drug pharmacokinetics in type 1 allergic mice induced by ovalbumin (OVA) emulsified with aluminum and inactive Bordetella pertussis. To further propose a possible key factor in drug-allergic disease interactions, we examined the inhibitory effect of NO, a marker of allergic conditions on the activities of major P450 isoforms”.
Zostavax uses a weakened form of the herpes zoster virus—commonly referred to as shingles—in order to activate the immune system
Plaintiffs allege that Zostavax caused even more serious complications, like blindness, hearing loss, paralysis, brain damage, and fatal liver failure.
Merck scientists accused the company of manipulating clinical test results.
Merck is currently battling another lawsuit for its mumps, measles, and rubella (MMR) vaccine. In 2010, two former Merck scientists accused the company of manipulating clinical test results to maintain its U.S. monopoly on the MMR vaccine. The court documents allege that Merck noticed in the late 1990s that the vaccine was falling below the 95 percent efficiency requirement necessary to sell the vaccine. Instead of improving the vaccine, Merck allegedly tinkered with the clinical trial results—which the two whistleblowers say they were asked to help carry out.
Many pharmaceutical companies are protected under the 1986 National Childhood Vaccine Injury Act, which requires that patients file injury claims with the federal government. However, Zostavax is not listed in the act’s injury table, allowing injured patients to file lawsuits in court.
Since the creation of the National Vaccine Injury Compensation Program, injured patients have received $3.6 billion. READ MORE…
Influenza vaccines seem to be modifying influenza into a dangerous dengue-like disease
The route of exposure for natural influenza infection is the respiratory tract, not subcutaneous (SC) or intramuscular (IM) injection. Influenza vaccines artificially changed the route of initial viral protein exposure to SC or IM injection thus making it similar to the route of exposure for dengue. The result is an IgE response to influenza proteins, similar to the response for dengue. It should therefore not come as a surprise that we are modifying the course of influenza infection such that it is acquiring characteristics of a dengue infection (hives and shock).